Regeneron Pharmaceuticals (REGN) Financial Ratios: P/E, ROE & More

Regeneron Pharmaceuticals (REGN) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Regeneron Pharmaceuticals had a P/E ratio of 17.58 (up from 17.37), return on equity of 14.9% (down from 16.0%), debt-to-equity of 0.10 (down from 0.10) and a current ratio of 4.13 (down from 4.73). A current ratio of 4.13 means current assets exceed current liabilities. Its dividend yield was 0.46% with a payout ratio of 8.2%.

Regeneron Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Valuation Ratios
P/E Ratio	17.58	17.37	23.63	17.76	8.18	14.51
Forward P/E	17.11	15.19	19.36	17.29	11.00	14.28
P/S Ratio	5.52	5.40	7.12	6.33	4.11	6.00
P/B Ratio	2.53	2.61	3.60	3.40	3.52	4.63
Price/Tangible Book	2.64	2.72	3.75	3.54	3.52	4.63
Price/FCF	19.41	20.91	24.10	17.41	10.11	25.45
Price/OCF	15.91	17.34	20.33	15.37	9.32	19.48
PEG Ratio	2.93	0.95	4.75	5.86	5.17	1.55
Enterprise Value Ratios
EV/Revenue	4.40	4.30	6.13	5.49	3.57	5.62
EV/EBITDA	14.88	13.19	17.28	12.51	6.17	12.25
EV/EBIT	17.06	14.73	19.00	13.37	6.37	13.04
EV/FCF	15.48	16.66	20.75	15.09	8.78	23.85
Profitability & Returns
Return on Equity (ROE)	14.87%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	5.91%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Invested Capital (ROIC)	13.04%	18.58%	22.38%	26.65%	60.13%	36.09%
Return on Capital Employed (ROCE)	10.20%	12.30%	14.30%	19.20%	41.80%	25.30%
Leverage & Solvency Ratios
Debt/Equity	0.10	0.10	0.11	0.12	0.14	0.24
Debt/EBITDA	0.69	0.63	0.60	0.52	0.29	0.69
Debt/FCF	0.73	0.80	0.72	0.63	0.41	1.34
Liquidity Ratios
Current Ratio	4.13	4.73	5.69	5.06	3.56	3.63
Quick Ratio	3.28	3.86	4.82	4.16	2.98	2.85
Efficiency Ratios
Asset Turnover	0.37	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.53	2.51	2.51	2.37	2.74	2.26
Yield & Distribution Ratios
Earnings Yield	5.69%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	5.15%	4.78%	4.15%	5.74%	9.89%	3.93%
Dividend Yield	0.46%	-	-	-	-	-
Payout Ratio	8.22%	-	-	-	-	-
Buyback Yield	5.65%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%
Total Return	6.10%	-1.23%	-0.18%	-1.16%	2.52%	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Regeneron Pharmaceuticals Financial Ratios

What is Regeneron Pharmaceuticals's P/E ratio?

Regeneron Pharmaceuticals's P/E ratio was 17.58 for fiscal 2025 (period ended Dec 31, 2025). It was 17.37 a year earlier.

What is Regeneron Pharmaceuticals's return on equity?

Regeneron Pharmaceuticals's return on equity (ROE) was 14.9% for fiscal 2025 (period ended Dec 31, 2025). It was 16.0% a year earlier.

What is Regeneron Pharmaceuticals's debt-to-equity ratio?

Regeneron Pharmaceuticals's debt-to-equity ratio was 0.10 for fiscal 2025 (period ended Dec 31, 2025). It was 0.10 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition